Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

"With this trial, the hope is to provide physicians with continuous, real-time pulmonary artery pressure ... 48 hours post-procedure as assessed by CT angiography. The primary safety endpoint ...

Akura Medical begins patient enrollment in QUADRA-PE study of Katana Thrombectomy System to treat acute pulmonary embolism: Los Gatos, California Thursday, February 6, 2025, 18:00 ...

Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study ...

Inquest hears Derek O’Neill did not receive prescribed anticoagulants for blood clots which ultimately led to his death ...

Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana thrombectomy system in treating acute pulmonary embolism (PE) patients.

Pulmonary Embolism Market Outlook 2025-2035: The 7 major pulmonary embolism market valued at USD 1.9 Billion in 2024. The IMARC Group predicts that the 7MM would reach USD 3.6 Billion by 2035, showing ...

142 patients suspected of having pulmonary embolism underwent spiral CT, scintigraphy, and (when indicated) pulmonary angiography. Pulmonary angiography was attempted if interpretations of spiral CT ...

Unlike in DVT due to other causes, pulmonary embolism is not a frequent association of MTS. We report a man in his 30s who presented with left lower limb pain and swelling, without chest pain or ...